Question 1

Does Frontier Capital Management own BBIO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Frontier Capital Management holds 1,373,057 shares of BBIO (Bridgebio Pharma), worth $102.3M.

Question 2

How many shares of BBIO does Frontier Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Frontier Capital Management holds 1,373,057 shares of BBIO (Bridgebio Pharma).

Question 3

What is Frontier Capital Management's BBIO position worth?

Accepted Answer

As of its Q2 2026 13F, Frontier Capital Management's BBIO position is worth $102.3M.

Question 4

Is Frontier Capital Management buying or selling BBIO?

Accepted Answer

In Q2 2026, Frontier Capital Management increased its BBIO position by 415,068 shares (+43.3%).

Question 5

When did Frontier Capital Management first buy BBIO?

Accepted Answer

Frontier Capital Management first reported BBIO in its Q1 2024 13F and has listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.4M	+43.3%	$102.3M	1.0%	$74.48	57
2026-Q1	Increased	957,989	+16.0%	$71.1M	0.7%	$74.26	48
2025-Q4	Increased	826,131	+25.2%	$63.2M	0.7%	$76.49	51
2025-Q3	Increased	659,633	+23.1%	$34.3M	0.3%	$51.94	42
2025-Q2	Decreased	535,763	-30.4%	$23.1M	0.2%	$43.18	0
2025-Q1	Decreased	769,301	-28.5%	$26.6M	0.3%	$34.57	0
2024-Q4	Increased	1.1M	+113.8%	$29.5M	0.3%	$27.44	56
2024-Q3	Increased	503,162	+239.1%	$12.8M	0.1%	$25.46	54

BBIOShowing 8 of 10 quarters

BBIO
Showing 8 of 10 quarters